UroGen Pharma Ltd. Ordinary Shares

URGNNASDAQ • USD
28.80 USD
↗ 0.70 (2.49%)🟢PRE MARKET (AS OF 08:31 AM EST)
🟢Market: OPEN

UroGen Pharma Ltd. Ordinary Shares (URGN) is currently trading at $28.80. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (52.5%) and a bullish Golden Cross on the moving averages. URGN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$27.66
High?$29.11
Low?$27.66
Prev. Close?$28.10
Volume?8.0K
Avg. Volume?1.3M
VWAP?$28.33
Rel. Volume?0.01x
Bid / Ask
Bid?$23.27 × 100
Ask?$32.30 × 100
Spread?$9.03
Midpoint?$27.78
Valuation & Ratios
Market Cap?1.4B
Shares Out?49.0M
Float?45.6M
Float %?93.3%
P/E Ratio?N/A
P/B Ratio?-11.01
EPS?-$1.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
Employees
291
Market Cap
1.3B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-05-04
Address
9 HA'TA'ASIYA ST
RA'ANANA, L3 4365007
Phone: 972 9 770 7601
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
98
Short Sent.?
65
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.73Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.20%High
Short Interest?5.1M
Days to Cover?5.1
Free Float45.6M
Avg Daily Volume1.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.40Strong
Quick Ratio?3.06Strong
Cash Ratio?1.16Strong
Debt/Equity?-1.54Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
S&P
97
-11.01CHEAP▾
P/S?
Peers
100
S&P
25
5.51FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-48.5CHEAP▾
EV/Sales?
Peers
100
S&P
28
5.94FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
91
52.5%STRONG▾
ROA?
S&P
3
-24.2%WEAK▾
Cash Flow & Enterprise
FCF?$-132049000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day